HIF1A and breast carcinoma: Consistent with our findings, ALKBH5 has been reported to positively regulate Nanog stability and expression in response to hypoxia-inducible factor (HIF)-1α and HIF-2α in breast cancer stem cells (BCSCs) (Zhang et al., 2016).